NCT05230082Completed
Acupuncture in Myasthenia Gravis (AcuMG)
Acupuncture Treatment for Individuals With Myasthenia Gravis
Source: ClinicalTrials.gov · Last updated 18 Sept 2025
Brief summary (registry, in English)
The purpose of the study is to determine the effect acupuncture treatment on individuals with a diagnosis of Myasthenia Gravis (MG). A total of 20 people with MG will be enrolled in this study to receive acupuncture treatment 2 times a week for 12 weeks. Participants will be randomized into two groups: 1) Immediate start and 2) Delayed start (12 weeks). The delayed start group will act as a control group for the first 12 weeks, but then receive acupuncture treatment for 12 weeks. It is hypothesized that patients with MG who receive acupuncture treatment will have improved quality of life and activities of daily living compared to no treatment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 24 (actual)
- First submitted
- 28 Jan 2022
- Start date
- 25 May 2022
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- HealthPartners Institute
- Diseases
- Myasthenia gravis
- NCT number
- NCT05230082
What you commit to
- Study type: Interventional
- Participants enrolled: 24
- From 25 May 2022 to the primary completion date, 30 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of any other serious neurological, psychiatric, chronic pain disorders, or seizures
- History of bleeding diathesis, other bleeding disorders, or syncope with needle puncture
- History of cardiac arrhythmia or current pacemaker, neurostimulator, or other implanted stimulation device
- Recent or active substance use disorder
- Any other medical conditions that could affect their ability to participate in acupuncture treatments for the study duration (as determined by study investigators)
Other
- Non-English speaking
- Participation in acupuncture treatment outside of the study, while enrolled
- Women who are currently pregnant, lactating, or planning to become pregnant during the study
- Active participation or past participation ≤3 months in any other interventional study.
- Unwilling to participate in all study related activities
Who the study is looking for
- Ability to provide and provision of signed and dated informed consent form
- Age 18-80
- Diagnosis of MG
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HealthPartners Neuroscience Center Coordinator of this site? Confirm its status | Saint Paul | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.